MSM Slides2005

STDs in Men Who Have Sex with MenSexually Transmitted Disease Surveillance 2005: 

STDs in Men Who Have Sex with Men Sexually Transmitted Disease Surveillance 2005 Division of STD Prevention

MSM Prevalence Monitoring Project — Number of gonorrhea tests and number of positive tests in men who have sex with men, STD clinics, 1999–2005: 

MSM Prevalence Monitoring Project — Number of gonorrhea tests and number of positive tests in men who have sex with men, STD clinics, 1999–2005 Note: The bars represent the number of GC tests at all anatomic sites (pharyngeal, rectal, and urethral) each year. The scales on the left and right axis differ. The bar graphs use the scale on the left. The line graphs use the scale on the right.

MSM Prevalence Monitoring Project — Number of gonorrhea tests and number of positive tests in men who have sex with men, STD clinics, 1999–2005: 

MSM Prevalence Monitoring Project — Number of gonorrhea tests and number of positive tests in men who have sex with men, STD clinics, 1999–2005 Note: The bars represent the number of GC tests at all anatomic sites (pharyngeal, rectal, and urethral) each year. The scales on the left and right axis differ. The bar graphs use the scale on the left. The line graphs use the scale on the right.

MSM Prevalence Monitoring Project — Syphilis serologic reactivity among men who have sex with men, STD clinics, 1999–2005: 

MSM Prevalence Monitoring Project — Syphilis serologic reactivity among men who have sex with men, STD clinics, 1999–2005 *Data not reported in 2004 and 2005.

MSM Prevalence Monitoring Project — Test positivity for gonorrhea, chlamydia, and HIV and seroreactivity to syphilis among men who have sex with men, byrace/ethnicity, STD clinics, 2005: 

MSM Prevalence Monitoring Project — Test positivity for gonorrhea, chlamydia, and HIV and seroreactivity to syphilis among men who have sex with men, by race/ethnicity, STD clinics, 2005 *Excludes persons previously known to be HIV-positive. Seroreactivity.

MSM Prevalence Monitoring Project —Test positivity for gonorrhea and chlamydia and syphilis seroreactivity among men who have sex with men,by HIV status, STD clinics, 2005: 

MSM Prevalence Monitoring Project —Test positivity for gonorrhea and chlamydia and syphilis seroreactivity among men who have sex with men, by HIV status, STD clinics, 2005 *Seroreactivity.

Gonococcal Isolate Surveillance Project (GISP) — Percent of urethral Neisseria gonorrhoeae isolates obtained from men who have sex with men attendingSTD clinics, 1988–2005: 

Gonococcal Isolate Surveillance Project (GISP) — Percent of urethral Neisseria gonorrhoeae isolates obtained from men who have sex with men attending STD clinics, 1988–2005

Gonococcal Isolate Surveillance Project (GISP) — Percent of Neisseria gonorrhoeae isolates obtained from men who have sex with men attending STD clinics, 2002–2005: 

Gonococcal Isolate Surveillance Project (GISP) — Percent of Neisseria gonorrhoeae isolates obtained from men who have sex with men attending STD clinics, 2002–2005 Note: Not all clinics participated in GISP for the last 4 years. Clinics include: ALB=Albuquerque, NM; ATL=Atlanta, GA; BAL=Baltimore, MD; BHM=Birmingham, AL; CHI=Chicago, IL; CIN=Cincinnati, OH; CLE=Cleveland, OH; DAL=Dallas, TX; DEN=Denver, CO; DTR=Detroit, MI; HON=Honolulu, HI; LAX=Los Angeles, CA; LBC=Long Beach, CA; LVG=Las Vegas, NV; MIA=Miami, FL; MIN=Minneapolis, MN; GRB=Greensboro, NC; NOR=New Orleans, LA; OKC=Oklahoma City, OK; ORA=Orange County, CA; PHI=Philadelphia, PA; PHX=Phoenix, AZ; POR=Portland, OR; SDG=San Diego, CA; SEA=Seattle, WA; SFO=San Francisco, CA; and TRP=Tripler Army Medical Center, HI (does not provide sexual risk behavior data).